The Latest SPAC News and Rumors: June 21, 2022

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Payment technology company Paya explores sale, Wag! announces promotion with Tractor Supply and Petsense, and Gelesis announces $15M pre-order for Plenity

Payment Technology Company Paya Is Said to Explore Sale 

Paya Holdings Inc. (NASDAQ:PAYA), a payments technology company that went public in 2020 through a blank-check deal, is exploring a potential sale amid takeover interest, according to people familiar with the matter.

Paya is working with an adviser to field interest, the people said, asking not to be identified because the matter is private. Large, publicly traded payments companies are circling the company as bidders, the people said.

Fintech Acquisition Corp. III secured shareholder approval for its $1.3 billion business combination with Paya in October 2020.

Wag! Announces Promotion With Tractor Supply and Petsense

Wag Labs, Inc. (“Wag!” or the “Company”), an American pet services marketplace company powering a mobile-first technology platform that enables on-demand and scheduled dog walking, training, and other pet care services today announced a promotion with Tractor Supply (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States, and its wholly-owned subsidiary Petsense to provide a range of pet service options to their customers. This promotion is exclusive to Tractor Supply and Petsense.

Wag! recently announced a definitive business combination agreement with CHW Acquisition Corporation (Nasdaq: CHWA) (“CHW”).

Gelesis Announces Additional $15 Million Pre-Order for Plenity, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million

Gelesis announced today that Ro, a leading and rapidly growing U.S. direct-to-patient healthcare company, has placed a $15 million pre-paid order for the company’s commercial product for weight management, Plenity®. This is in addition to previous Plenity pre-orders from Ro totaling $40 million.

Capstar Special Purpose Acquisition Corp. completed its business combination with biotherapeutics firm Gelesis on January 12, 2022.